Northland raised the firm’s price target on Astera Labs (ALAB) to $225 from $195 and keeps an Outperform rating on the shares. The firm lift its estimates after the company reported “a solid quarter and guided up.”
Meet Samuel – Your Personal Investing Prophet
LABX: an alternative to margin or options on ALABPublished first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALAB:
- Quinn Bolton Lifts Astera Labs Price Target to $260 on Strong Product Momentum and Long-Term AI Growth Drivers
- Astera Labs Earns Buy Rating on Strong Q1 Results, Surging Scorpio AI Switch Demand, and Expanding Connectivity Portfolio
- Sean O’Loughlin Reiterates Hold on Astera, Lifts Price Target to $225 Amid Strong Near-Term Upside but Longer-Term Competitive Uncertainty
- Astera Labs’ Earnings Call Highlights Explosive AI Growth
- Astera Labs Inc options imply 11.1% move in share price post-earnings